Nomura Micro Science: 21 fiscal years of results, 2006–2026
- Revenue · FYE Mar 2026
- ¥56bn
- Operating profit · FYE Mar 2026
- ¥6.7bn
- Net profit · FYE Mar 2026
- ¥3.8bn
- Total assets
- ¥110bn
- Equity ratio
- 36.1%
- Fiscal years on record
- 21 · 2006–2026
This page carries 21 fiscal years of results, from 2006 to 2026. Revenue peaked in 2025 and has not returned to that level since. The company reported a net loss in 4 years: 2010, 2013, 2014, 2015.
| Fiscal year | Unit | 2006 FYE Mar | 2007 FYE Mar | 2008 FYE Mar | 2009 FYE Mar | 2010 FYE Mar | 2011 FYE Mar | 2012 FYE Mar | 2013 FYE Mar | 2014 FYE Mar | 2015 FYE Mar | 2016 FYE Mar | 2017 FYE Mar | 2018 FYE Mar | 2019 FYE Mar | 2020 FYE Mar | 2021 FYE Mar | 2022 FYE Mar | 2023 FYE Mar | 2024 FYE Mar | 2025 FYE Mar | 2026 FYE Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | JPY | ¥19bn | ¥27bn | ¥25bn | ¥21bn | ¥11bn | ¥22bn | ¥17bn | ¥13bn | ¥15bn | ¥12bn | ¥18bn | ¥17bn | ¥22bn | ¥25bn | ¥21bn | ¥30bn | ¥32bn | ¥50bn | ¥73bn | ¥96bn | ¥56bn |
| YoY | % | — | +47.0% | -8.1% | -14.4% | -46.7% | +93.0% | -25.0% | -19.4% | +12.8% | -19.3% | +47.1% | -7.3% | +30.9% | +16.2% | -16.3% | +44.8% | +4.9% | +55.5% | +47.2% | +32.1% | -41.7% |
| Operating profit | JPY | — | ¥1.9bn | ¥1.4bn | ¥0.8bn | -¥0.4bn | ¥1.2bn | ¥0.6bn | -¥0.4bn | -¥0.7bn | -¥0.5bn | ¥0.3bn | ¥0.8bn | ¥1.2bn | ¥1.2bn | ¥1.8bn | ¥4.0bn | ¥4.4bn | ¥6.6bn | ¥11bn | ¥15bn | ¥6.7bn |
| YoY | % | — | — | -26.3% | -42.9% | -150.0% | — | -50.0% | -166.7% | — | — | — | +166.7% | +50.0% | 0.0% | +50.0% | +122.2% | +10.0% | +50.0% | +60.6% | +45.3% | -56.5% |
| Ordinary profit | JPY | — | ¥1.9bn | ¥0.8bn | ¥0.3bn | -¥0.5bn | ¥0.7bn | ¥0.5bn | ¥0.0bn | -¥0.4bn | -¥0.3bn | ¥0.2bn | ¥0.7bn | ¥1.1bn | ¥1.2bn | ¥1.8bn | ¥3.6bn | ¥4.6bn | ¥6.4bn | ¥11bn | ¥13bn | ¥5.6bn |
| Net profit | JPY | — | ¥1.1bn | ¥0.3bn | ¥0.1bn | -¥0.5bn | ¥0.4bn | ¥0.2bn | -¥0.1bn | -¥0.4bn | -¥1.0bn | ¥0.2bn | ¥0.7bn | ¥1.0bn | ¥1.0bn | ¥1.3bn | ¥2.6bn | ¥3.3bn | ¥5.8bn | ¥8.0bn | ¥10bn | ¥3.8bn |
| YoY | % | — | — | -72.7% | -66.7% | -600.0% | — | -50.0% | -150.0% | — | — | — | +250.0% | +42.9% | 0.0% | +30.0% | +100.0% | +26.9% | +75.8% | +37.9% | +27.5% | -62.7% |
| Operating margin | % | — | 7.0% | 5.6% | 3.7% | -3.5% | 5.5% | 3.6% | -3.0% | -4.7% | -4.1% | 1.7% | 4.8% | 5.6% | 4.8% | 8.6% | 13.2% | 13.8% | 13.3% | 14.5% | 16.0% | 11.9% |
| Net margin | % | — | 4.0% | 1.2% | 0.5% | -4.4% | 1.8% | 1.2% | -0.8% | -2.7% | -8.3% | 1.1% | 4.2% | 4.6% | 4.0% | 6.2% | 8.6% | 10.3% | 11.7% | 11.0% | 10.6% | 6.8% |
| Standard | Japanese GAAP | Japanese GAAP | Japanese GAAP | Japanese GAAP | Japanese GAAP | Japanese GAAP | Japanese GAAP | Japanese GAAP | Japanese GAAP | Japanese GAAP | Japanese GAAP | Japanese GAAP | Japanese GAAP | Japanese GAAP | Japanese GAAP | Japanese GAAP | Japanese GAAP | Japanese GAAP | Japanese GAAP | Japanese GAAP | Japanese GAAP | |
| Basis | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated | Consolidated |
Where each yen of revenue goes — cost of sales, SG&A and what is left as operating profit (¥ bn, stacked)
| Fiscal year | Unit | 2007 *1 FYE Mar | 2008 *1 FYE Mar | 2009 *1 FYE Mar | 2010 *1 FYE Mar | 2011 *1 FYE Mar | 2012 *1 FYE Mar | 2013 *1 FYE Mar | 2014 *1 FYE Mar | 2015 *1 FYE Mar | 2016 *1 FYE Mar | 2017 *1 FYE Mar | 2018 *1 FYE Mar | 2019 *1 FYE Mar | 2020 *1 FYE Mar | 2021 *1 FYE Mar | 2022 *1 FYE Mar | 2023 *1 FYE Mar | 2024 *1 FYE Mar | 2025 *1 FYE Mar | 2026 *1 FYE Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | JPY | ¥27bn | ¥25bn | ¥21bn | ¥11bn | ¥22bn | ¥17bn | ¥13bn | ¥15bn | ¥12bn | ¥18bn | ¥16bn | ¥22bn | ¥25bn | ¥21bn | ¥30bn | ¥32bn | ¥50bn | ¥73bn | ¥96bn | ¥56bn |
| YoY | % | — | -8.3% | -14.3% | -46.6% | +92.8% | -24.9% | -19.6% | +12.8% | -19.2% | +46.7% | -7.4% | +31.3% | +16.3% | -16.2% | +44.2% | +5.1% | +55.5% | +47.2% | +32.0% | -41.6% |
| Cost of sales | JPY | ¥22bn | ¥21bn | ¥18bn | ¥9.3bn | ¥18bn | ¥13bn | ¥11bn | ¥13bn | ¥9.7bn | ¥14bn | ¥13bn | ¥17bn | ¥21bn | ¥16bn | ¥23bn | ¥24bn | ¥39bn | ¥58bn | ¥75bn | ¥44bn |
| SG&A | JPY | ¥3.1bn | ¥3.0bn | ¥2.7bn | ¥2.5bn | ¥2.7bn | ¥2.6bn | ¥2.7bn | ¥2.9bn | ¥3.0bn | ¥3.0bn | ¥2.9bn | ¥3.1bn | ¥3.1bn | ¥3.2bn | ¥3.2bn | ¥3.2bn | ¥3.8bn | ¥4.8bn | ¥5.7bn | ¥6.0bn |
| Operating profit | JPY | ¥1.9bn | ¥1.4bn | ¥0.8bn | -¥0.4bn | ¥1.2bn | ¥0.6bn | -¥0.4bn | -¥0.7bn | -¥0.5bn | ¥0.3bn | ¥0.8bn | ¥1.2bn | ¥1.2bn | ¥1.8bn | ¥4.0bn | ¥4.4bn | ¥6.6bn | ¥11bn | ¥15bn | ¥6.7bn |
| YoY | % | — | -27.4% | -43.1% | -148.5% | — | -50.8% | -165.4% | — | — | — | +143.1% | +61.2% | -2.2% | +52.1% | +115.2% | +11.6% | +47.8% | +62.6% | +44.4% | -56.6% |
| Operating margin | % | 7.0% | 5.6% | 3.7% | -3.4% | 5.5% | 3.6% | -2.9% | -4.6% | -4.5% | 1.8% | 4.7% | 5.7% | 4.8% | 8.8% | 13.1% | 13.9% | 13.2% | 14.6% | 16.0% | 11.9% |
| Change | pp | — | -1.4pp | -1.9pp | -7.1pp | +8.9pp | -1.9pp | -6.5pp | -1.7pp | +0.1pp | +6.3pp | +2.9pp | +1.0pp | -0.9pp | +4.0pp | +4.3pp | +0.8pp | -0.7pp | +1.4pp | +1.4pp | -4.1pp |
- *1 Securities report (yuka shoken hokokusho), as filed
Total assets, equity and interest-bearing debt (¥ bn), with the equity ratio (%)
| Fiscal year | Unit | 2012 *1 FYE Mar | 2013 *1 FYE Mar | 2014 *1 FYE Mar | 2015 *1 FYE Mar | 2016 *1 FYE Mar | 2017 *1 FYE Mar | 2018 *1 FYE Mar | 2019 *1 FYE Mar | 2020 *1 FYE Mar | 2021 *1 FYE Mar | 2022 *1 FYE Mar | 2023 *1 FYE Mar | 2024 *1 FYE Mar | 2025 *1 FYE Mar | 2026 *1 FYE Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | JPY | ¥16bn | ¥16bn | ¥16bn | ¥14bn | ¥15bn | ¥17bn | ¥22bn | ¥19bn | ¥20bn | ¥25bn | ¥27bn | ¥42bn | ¥71bn | ¥117bn | ¥110bn |
| YoY | % | — | +1.6% | -0.7% | -8.8% | +6.5% | +9.2% | +33.1% | -13.9% | +3.1% | +26.2% | +9.4% | +54.7% | +68.4% | +65.4% | -5.6% |
| Equity | JPY | ¥8.1bn | ¥8.1bn | ¥7.8bn | ¥7.2bn | ¥7.0bn | ¥7.8bn | ¥8.8bn | ¥9.5bn | ¥10bn | ¥13bn | ¥16bn | ¥21bn | ¥29bn | ¥37bn | ¥40bn |
| YoY | % | — | -0.1% | -4.5% | -7.1% | -3.4% | +11.4% | +13.4% | +8.7% | +8.0% | +27.9% | +20.8% | +34.3% | +35.2% | +28.0% | +7.7% |
| Interest-bearing debt | JPY | — | — | — | ¥3.7bn | ¥4.0bn | ¥3.9bn | ¥6.1bn | ¥4.0bn | ¥3.2bn | ¥2.6bn | ¥2.7bn | ¥3.4bn | ¥22bn | ¥52bn | ¥51bn |
| Equity ratio | % | 52.4% | 51.5% | 49.5% | 50.4% | 45.7% | 46.7% | 39.8% | 50.2% | 52.6% | 53.3% | 58.8% | 51.1% | 41.0% | 31.7% | 36.1% |
| Change | pp | — | -0.9pp | -2.0pp | +0.9pp | -4.7pp | +1.0pp | -6.9pp | +10.4pp | +2.4pp | +0.7pp | +5.5pp | -7.7pp | -10.1pp | -9.3pp | +4.4pp |
- *1 Securities report (yuka shoken hokokusho), as filed
Cash generated by operations, spent on investment and raised or repaid in financing (¥ bn)
| Fiscal year | Unit | 2006 *1 FYE Mar | 2007 *1 FYE Mar | 2008 *1 FYE Mar | 2009 *1 FYE Mar | 2010 *1 FYE Mar | 2011 *1 FYE Mar | 2012 *1 FYE Mar | 2013 *1 FYE Mar | 2014 *1 FYE Mar | 2015 *1 FYE Mar | 2016 *1 FYE Mar | 2017 *1 FYE Mar | 2018 *1 FYE Mar | 2019 *1 FYE Mar | 2020 *1 FYE Mar | 2021 *1 FYE Mar | 2022 *1 FYE Mar | 2023 *1 FYE Mar | 2024 *1 FYE Mar | 2025 *1 FYE Mar | 2026 *1 FYE Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | JPY | ¥0.2bn | ¥0.8bn | -¥1.4bn | -¥1.6bn | ¥3.4bn | ¥0.1bn | ¥1.3bn | ¥0.7bn | ¥0.3bn | ¥0.8bn | -¥0.3bn | ¥1.2bn | -¥2.0bn | ¥3.6bn | -¥0.2bn | ¥6.0bn | ¥1.1bn | ¥4.7bn | -¥19bn | -¥20bn | ¥4.4bn |
| YoY | % | — | +446.1% | -261.6% | — | — | -98.4% | +2195.2% | -41.7% | -62.1% | +165.3% | -134.0% | — | -261.5% | — | -106.7% | — | -81.0% | +313.4% | -498.6% | — | — |
| Investing CF | JPY | -¥0.1bn | -¥0.5bn | -¥0.1bn | -¥1.8bn | -¥0.2bn | -¥0.1bn | -¥0.1bn | -¥0.5bn | -¥0.9bn | ¥0.0bn | -¥0.6bn | -¥0.3bn | -¥1.1bn | ¥0.5bn | -¥1.0bn | -¥0.4bn | ¥0.1bn | ¥0.1bn | ¥0.4bn | -¥2.7bn | -¥1.1bn |
| Financing CF | JPY | -¥0.4bn | -¥0.3bn | ¥1.9bn | ¥2.0bn | -¥1.4bn | -¥0.2bn | -¥1.2bn | ¥0.4bn | -¥0.3bn | -¥0.3bn | ¥0.4bn | -¥0.1bn | ¥2.2bn | -¥2.2bn | -¥1.0bn | -¥0.9bn | -¥0.9bn | -¥0.0bn | ¥17bn | ¥27bn | -¥6.9bn |
| Cash & equivalents | JPY | ¥3.3bn | ¥3.6bn | ¥3.9bn | ¥2.4bn | ¥4.2bn | ¥3.5bn | ¥3.5bn | ¥4.5bn | ¥3.6bn | ¥4.4bn | ¥3.7bn | ¥4.6bn | ¥3.6bn | ¥5.5bn | ¥3.1bn | ¥8.0bn | ¥8.4bn | ¥13bn | ¥12bn | ¥17bn | ¥9.9bn |
| YoY | % | — | +6.5% | +9.8% | -38.5% | +75.9% | -17.4% | +0.4% | +28.4% | -19.1% | +20.0% | -15.8% | +23.9% | -20.1% | +49.5% | -42.8% | +155.5% | +6.1% | +56.4% | -10.3% | +39.5% | -39.9% |
- *1 Securities report (yuka shoken hokokusho), as filed
Profitability and balance-sheet strength (%). ROE uses year-end equity.
| Fiscal year | Unit | 2007 *1 FYE Mar | 2008 *1 FYE Mar | 2009 *1 FYE Mar | 2010 *1 FYE Mar | 2011 *1 FYE Mar | 2012 *1 FYE Mar | 2013 *1 FYE Mar | 2014 *1 FYE Mar | 2015 *1 FYE Mar | 2016 *1 FYE Mar | 2017 *1 FYE Mar | 2018 *1 FYE Mar | 2019 *1 FYE Mar | 2020 *1 FYE Mar | 2021 *1 FYE Mar | 2022 *1 FYE Mar | 2023 *1 FYE Mar | 2024 *1 FYE Mar | 2025 *1 FYE Mar | 2026 *1 FYE Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | % | 7.0% | 5.6% | 3.7% | -3.4% | 5.5% | 3.6% | -2.9% | -4.6% | -4.5% | 1.8% | 4.7% | 5.7% | 4.8% | 8.8% | 13.1% | 13.9% | 13.2% | 14.6% | 16.0% | 11.9% |
| Change | pp | — | -1.4pp | -1.9pp | -7.1pp | +8.9pp | -1.9pp | -6.5pp | -1.7pp | +0.1pp | +6.3pp | +2.9pp | +1.0pp | -0.9pp | +4.0pp | +4.3pp | +0.8pp | -0.7pp | +1.4pp | +1.4pp | -4.1pp |
| Net margin | % | 3.9% | 1.2% | 0.4% | -4.3% | 2.8% | 0.9% | -0.8% | -2.7% | -8.1% | 0.9% | 4.2% | 4.6% | 4.1% | 6.0% | 8.6% | 10.3% | 11.7% | 10.9% | 10.6% | 6.8% |
| Change | pp | — | -2.7pp | -0.8pp | -4.7pp | +7.1pp | -1.9pp | -1.7pp | -1.9pp | -5.4pp | +9.0pp | +3.3pp | +0.4pp | -0.5pp | +1.9pp | +2.6pp | +1.7pp | +1.4pp | -0.8pp | -0.3pp | -3.8pp |
| ROE | % | — | — | — | — | — | 1.9% | -1.3% | -5.2% | -13.7% | 2.2% | 8.9% | 11.4% | 10.8% | 12.3% | 19.9% | 20.7% | 27.1% | 27.6% | 27.6% | 9.6% |
| Change | pp | — | — | — | — | — | — | -3.2pp | -3.9pp | -8.5pp | +15.9pp | +6.7pp | +2.5pp | -0.6pp | +1.5pp | +7.6pp | +0.8pp | +6.4pp | +0.5pp | 0.0pp | -18.0pp |
| Equity ratio | % | — | — | — | — | — | 52.4% | 51.5% | 49.5% | 50.4% | 45.7% | 46.7% | 39.8% | 50.2% | 52.6% | 53.3% | 58.8% | 51.1% | 41.0% | 31.7% | 36.1% |
| Change | pp | — | — | — | — | — | — | -0.9pp | -2.0pp | +0.9pp | -4.7pp | +1.0pp | -6.9pp | +10.4pp | +2.4pp | +0.7pp | +5.5pp | -7.7pp | -10.1pp | -9.3pp | +4.4pp |
- *1 Securities report (yuka shoken hokokusho), as filed
The revenue line above, converted at the average ¥/US$ rate of each figure’s own year — never today’s.
Between 2006–2026, Nomura Micro Science’s revenue grew 3.0-fold in yen (5.7% a year). Converted at each year’s own average rate, the same span is 2.2-fold in dollars (4.1% a year), from $159m to $355m. The dollar figure grew more slowly because the yen weakened over the period: part of the growth an investor sees in yen does not survive translation into dollars.
| Fiscal year | Unit | 2006 *4 FYE Mar | 2007 *4 FYE Mar | 2008 *4 FYE Mar | 2009 *4 FYE Mar | 2010 *4 FYE Mar | 2011 *4 FYE Mar | 2012 *4 FYE Mar | 2013 *4 FYE Mar | 2014 *4 FYE Mar | 2015 *4 FYE Mar | 2016 *4 FYE Mar | 2017 *4 FYE Mar | 2018 *4 FYE Mar | 2019 *4 FYE Mar | 2020 *4 FYE Mar | 2021 *4 FYE Mar | 2022 *4 FYE Mar | 2023 *4 FYE Mar | 2024 *4 FYE Mar | 2025 *4 FYE Mar | 2026 *4,5 FYE Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | USD | $159m | $231m | $242m | $229m | $130m | $276m | $207m | $136m | $142m | $100m | $164m | $147m | $196m | $230m | $197m | $277m | $243m | $353m | $482m | $644m | $355m |
| YoY | % | — | +45.2% | +4.8% | -5.4% | -43.2% | +112.3% | -25.0% | -34.1% | +4.0% | -29.5% | +63.6% | -10.0% | +33.0% | +17.7% | -14.6% | +40.8% | -12.3% | +45.4% | +36.5% | +33.7% | -44.8% |
| Revenue as filed | JPY | ¥19bn | ¥27bn | ¥25bn | ¥21bn | ¥11bn | ¥22bn | ¥17bn | ¥13bn | ¥15bn | ¥12bn | ¥18bn | ¥17bn | ¥22bn | ¥25bn | ¥21bn | ¥30bn | ¥32bn | ¥50bn | ¥73bn | ¥96bn | ¥56bn |
| Rate applied | ¥/US$ | ¥116.28 | ¥117.77 | ¥103.33 | ¥93.53 | ¥87.77 | ¥79.78 | ¥79.79 | ¥97.60 | ¥105.84 | ¥121.02 | ¥108.84 | ¥112.16 | ¥110.40 | ¥109.01 | ¥106.78 | ¥109.78 | ¥131.37 | ¥140.51 | ¥151.50 | ¥149.65 | ¥158.16 |
- *1 1949-1971: Fixed Bretton Woods peg ¥360/$ (Dodge Line 1949; Smithsonian ¥308 from Dec 1971).
- *2 1972: Smithsonian peg ¥308/$ (held until Feb 1973 float).
- *3 1973-1979: JIL (Japan Institute for Labour Policy and Training) g0001.xlsx — fiscal-year (Apr–Mar) basis, integer-rounded. PROVISIONAL; upgrade to BOJ FXERM07 calendar-year later.
- *4 1980-2026: Bank of Japan stat-search FM08'FXERM07 (Tokyo market, USD/JPY spot, 17:00 fixing, monthly average) — calendar-year average of monthly averages.
- *5 Provisional — part-year average, not a full calendar year.
Which accounting standard each stretch of the series was filed under, and whether the accounts are consolidated.
Every year on record was filed on the same basis — consolidated Japanese GAAP — so the series is comparable end to end.
| Fiscal years | Standard | Basis | Years |
|---|---|---|---|
| 2006–2026 | Japanese GAAP | consolidated | 21 |
All figures are in Japanese yen as filed. Where a foreign-currency comparison is needed elsewhere on this site, yen amounts are converted at the average rate of each figure's own year — not today's rate. Exchange rates & sources →
Read the company history → 日本語版(詳細)— full financial data in Japanese →
Data API
Nomura Micro Science’s history, financials, executives and
shareholders are published as static JSON — no key, plain GET.
Full specification →
/api/6254/manifest.json ·/api/6254/history.json ·/api/6254/timeline.json ·/api/6254/decisions.json ·/api/6254/executives.json ·/api/6254/shareholders.json ·/api/6254/financials.json ·/api/6254/financials-longterm.json ·/api/6254/segments.json ·/api/6254/regions.json ·/api/6254/workforce.json · /api/6254/decisions/{slug}.json